valsartan_hydrochlorothiazide: profile and news

FDA Approves Higher Dose Formulations of Diovan HCT (valsartan ...  May 1, 2006
Administration (FDA) approved two new, higher dose formulations of the high blood pressure medication Diovan HCT(R) (valsartan/hydrochlorothiazide): 320/12.5 ... - PharmaLive.com (press release),

(PRN) - Price Legacy Corporation Declares Series 1 Preferred Stock ...  May 1, 2006
...[+]. (PRN) - FDA Approves Higher Dose Formulations of Diovan HCT(R) (valsartan/hydrochlorothiazide) for Treatment of High Blood Pressure ... [+. ... - Bolsamania.com,